Biosenta Inc. announced a non-brokered private placement financing to issue 1,250,000 units at an issue price of CAD 0.40 per unit for the gross proceeds of CAD 500,000 on December 15, 2023. Each Unit will consist of one common share and one half of common share purchase warrant. Each Warrant will entitle the holder thereof to acquire, subject to adjustment in certain events, one common share at an exercise price of CAD 0.80 for a period of 18 months from the closing date of the Offering.

The closing of the Offering is expected to occur on or about December 22, 2023, or such other date or dates as the Company may determine. The securities issued pursuant to the Offering shall be subject to a four-month plus one day hold period from the closing date in accordance with applicable Canadian securities laws.